Here are highlights from Tuesday’s Analyst Blog:
Chicago, IL – January 15, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...
The Zacks Analyst Blog Highlights J&J, Eli Lilly, GSK and Intra-Cellular
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...
Cancer Therapy Advisor16h
SABCS 2024: Research Roundup
Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.
BioPharma Dive21h
JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended that Keytruda's coming loss of ...
Hosted on MSN22h
J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies
Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire Intra-Cellular Therapies, a company whose main asset has the potential to ...
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...
Hosted on MSN23h
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
The JP Morgan Healthcare Conference, which is being held in San Francisco this year, has been much more active than last year. Among some of the top news at the conference were M&A deal announcements ...